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Essentials of Pharmacoeconomics is an introductory textbook ori-
ented for US pharmacy students. It provides an understanding
and application of the principles of pharmacoeconomics based
on the experiences of a highly regarded academician, Dr. Ras-
cati, who is well-versed in both teaching and research at the
University of Texas School of Pharmacy. The book has received
three positive reviews thus far, one of which focused on the
angle of a pharmacy educator [1], which has served to highlight
the merits of the contribution of this text. Another was written
by an editor of a journal who systematically reviewed the book
chapter by chapter [2]. The third review was written by a grad-
uate student in biotechnology that served to defend why this
book should serve as an entry-level book for pharmacy students
interested in studying pharmacoeconomics [3]. In terms of the
contribution of this review, we are interested in taking the ap-
proach that it is the value that it provides us, as pharmacy
educators and students who have been using the textbook in
our outcomes research course focused on providing third-year
PharmD students at the University of Utah College of Pharmacy
an appreciation of the tools used in pharmacoeconomics and
outcomes research. What follows is a review of each chapter of
the textbook:
1. Chapter 1 (Introduction) provides a relatively comprehensive
overview of the basic topics relevant to understanding the im-
portance and clinical relevance of pharmacoeconomics. The
chapter offers questions/exercises at the end along with sug-
gested readings. Overall, the chapter served its intended pur-
pose of introducing the basic components of pharmacoeco-
nomics and outcomes research and the relevance of the
material to pharmacists.
. Chapter 2 (Measuring and Estimating Costs) expands across a
variety of areas including defining various types of costing
terms anddetermining the perspective of the study taken. Good
examples are provided alongwith questions/exercises and sug-
gested readings.
. Chapter 3 (Critiquing Research Articles) runs through the vari-
ous questions to consider when reviewing a pharmacoeco-
nomic research article. Good examples are provided along
with questions/exercises providing the student with the op-
portunity to critique an abstract along with suggested read-
ings. The concern that we have is that an abstract is used for
the purpose of the critique, whereas a paper would have been
far more appropriate as an exercise. We required that our
students critique papers that we chose and distributed to
them. They then actively critiqued the article and presentedit to the class. They were evaluated on the manner in which
they performed the critique.
4. Chapters 4 (Cost-Minimization Analysis), 5 (Cost-Effectiveness
Analysis), 6 (Cost-Utility Analysis), and 7 (Cost-Benefit Analysis)
define and describe the various types of economic analysis.
Good examples are provided throughout each chapter along
with good questions/exercises. Each chapter provides a com-
posite article for the students to critique along with suggested
readings.
5. Chapter 8 (Health-Related Quality of Life: Health Status Mea-
sures) covers the understanding and use of health-related qual-
ity of life. A composite article is presented at the end that re-
quires a critique by the students along with other questions/
answers and suggested readings. This particular chapter
should have been required reading before Chapter 6 (Cost-Util-
ity Analysis) because the discussion of quality of life–related
termswould have enhanced the student’s ability to perform the
cost-utility analysis.
6. Chapters 9 (Decision Analysis) and 10 (Markov Modeling) were
well written. The composite articles requiring a critique and the
questions/exercises were very good and appreciated alongwith
the suggested readings.
7. Chapter 11 (Retrospective Databases) provided a good under-
standing of retrospective and prospectively gathered data.
The composite article requiring a critique at the end of the
chapter was very good as were the questions/exercises pro-
vided.
8. Chapters 12 (Pharmacy Services), 13 (International Perspec-
tive), 14 (Future Issues), and the glossary (contained at the
end of the textbook) rounded off the text very nicely because
it offered our students material relevant to their profession.
Overall our students appeared to enjoy this textbook. For the
most part, the composite review articles provided were appropri-
ate as were the questions/exercises provided. Chapters 4 through
7, which focused on the various types of economic analysis, were
very good. Ideally the decision-tree analysis (DTA) and Markov
modeling chapters may have benefited from Excel spreadsheet–
driven examples. We had to take the initiative and develop our
own Excel spreadsheets as part of the learning examples associ-
ated with this chapter. Likewise we took the initiative to also in-
troduce the students to appropriate software (e.g., Treeage Data)
to use to better their understanding of DTA.
Overall, compared to other textbooks that we have used in the
classroom to teach pharmacoeconomics, Dr. Rascati’s book fared
better because it provided exercises at the end of each chapter to
help the student engage in problem-based learning. Also, the text
is written solely by one author, which helps it to flow well. One
serious limitation that we found with the exercises at the end of
each chapter is that they do not contain the original reference to
the work, which we believe should be provided.
[617V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 6 1 6 – 6 1 7We would recommend this textbook to other educators inter-
ested in teaching an introductory course on pharmacoeconomics
and outcomes research to pharmacy students.
R E F E R E N C E S
[1] Liu Y. Book review of Essentials of Pharmacoeconomics. Am J Pharm
Educ 2009;73:article 94.[2] Carswell CI. Book review of Essentials of Pharmacoeconomics.
Pharmacoeconomics 2008;26:1065.3] King H. Book review of Essentials of Pharmacoeconomics. J Commer
Biotechnol 2009;15:92–4.
Carl V. Asche, PhD
Joe Biskupiak, PhD, MBA
University of Utah College of Pharmacy, Salt lake City, UT, USA
1098-3015/$36.00 – see front matter
Copyright © 2011, International Society for Pharmacoeconomics
and Outcomes Research (ISPOR). Published by Elsevier Inc.doi:10.1016/j.jval.2010.11.007
